Literature DB >> 20009899

18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.

Timothy N Showalter1, Tom R Miller, Phyllis Huettner, Janet Rader, Perry W Grigsby.   

Abstract

PURPOSE: Cervical cancer tumor size determined by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) thresholding of the maximum standardized uptake value (SUVMax) has been correlated with the determined tumor size by computed tomography and magnetic resonance imaging. The purpose of this study was to evaluate the relationship between preoperative FDG-PET tumor size and pathologic tumor diameter in patients with early-stage cervical cancer who were undergoing radical hysterectomy. PATIENTS AND METHODS: Forty patients with early-stage cervical cancer underwent pretreatment FDG-PET/computed tomography before radical hysterectomy and lymph node dissection. Primary tumor diameter was defined on FDG-PET as the largest diameter of the 3-dimensional volumetric isocontour of the 40% threshold of the SUVMax. The FDG-PET measurements were compared with the tumor diameter and the histological diameter of the pathologic specimen using regression analysis, paired t test, and unpaired t test.
RESULTS: The FDG-PET tumor diameter measurements were correlated to the pathologic tumor diameter in the surgical specimen with a coefficient of determination (R2) of 0.951 and a correlation coefficient of 0.757 (P < 0.0001).
CONCLUSION: There is a high level of correlation in the FDG-PET and the pathologic tumor measurements in the early-stage cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009899     DOI: 10.1111/IGC.0b013e3181b62e8c

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG.

Authors:  Daniel L J Thorek; Diane S Abou; Bradley J Beattie; Rachel M Bartlett; Ruimin Huang; Pat B Zanzonico; Jan Grimm
Journal:  J Nucl Med       Date:  2012-08-07       Impact factor: 10.057

2.  FDG-PET-based prognostic nomograms for locally advanced cervical cancer.

Authors:  Elizabeth A Kidd; Issam El Naqa; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

3.  Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix.

Authors:  Jeffrey R Olsen; Jacqueline Esthappan; Todd DeWees; Vamsi R Narra; Farrokh Dehdashti; Barry A Siegel; Julie K Schwarz; Perry W Grigsby
Journal:  J Magn Reson Imaging       Date:  2012-09-28       Impact factor: 4.813

4.  Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.

Authors:  Fei Yang; Maria A Thomas; Farrokh Dehdashti; Perry W Grigsby
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-23       Impact factor: 9.236

5.  Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.

Authors:  Weina Xu; Shupeng Yu; Ying Ma; Changping Liu; Jun Xin
Journal:  Nucl Med Commun       Date:  2017-03       Impact factor: 1.690

6.  The effect of different segmentation methods on primary tumour metabolic volume assessed in 18F-FDG-PET/CT in patients with cervical cancer, for radiotherapy planning.

Authors:  Paulina Cegła; Ewa Burchardt; Ewa Wierzchosławska; Andrzej Roszak; Witold Cholewiński
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.